Allergic lung responses are increased in prostaglandin H synthase- deficient mice

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 721-732

  Gavett, Stephen H ^a   Madison, Sharon L ^a   Chulada, Patricia C ^b   Scarborough, Paula E ^b   Qu, Wei ^b   Boyle, James E ^b   Tiano, Howard F ^b   Lee, Christopher A ^b   Langenbach, Robert ^b   Roggli, Victor L ^c   Zeldin, Darryl C ^b  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; METHACHOLINE; OVALBUMIN; PROSTAGLANDIN SYNTHASE;

ALLERGIC ASTHMA; ANIMAL MODEL; ARACHIDONIC ACID METABOLISM; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; INFLAMMATION; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RESPIRATORY TRACT ALLERGY;

EID: 0032748025     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6890     Document Type: Article

References (43)

1. Holtzman, M.J. 1991. Arachidonic acid metabolism: implications of biological chemistry for lung function and disease. Am. Rev. Respir. Dis. 143:188-203.
2. Wenzel, S.E. 1997. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy. 17:3S-12S.
3. 4 and to methacholine in patients with asthma and normal controls. N. Engl. J. Med. 315:480-484.
4. Henderson, W.R., et al. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483-1494.
5. Drazen, J.M., Israel, E., and O'Byrne, P.M. 1999. Treatment of asthma with drugs modifying the leukotriene pathway. N. Engl. J. Med. 340:197-206.
6. Irvin, C.G., Tu, Y.-P., Sheller, J.R., and Funk, C.D. 1997. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol. 272:L1053-L1058.
7. 2 into human airways during acute antigen challenge. N. Engl. J. Med. 315:800-804.
8. 2 in normal and asthmatic men. N. Engl. J. Med. 311:209-213.
9. 2 on airway conductance in healthy subjects and asthmatic patients. Am. Rev. Respir Dis. 111:313-319.
10. Niki, H., Tominaga, Y., Watanabe-Kobayashi, M., Mue, S., and Ohuchi, K. 1997. Possible participation of cyclooxygenase-2 in the recurrence of allergic inflammation in rats. Eur. J. Pharmacol. 320:193-200.
11. Kuitert, L.M., Newton, R., Barnes, N.C., Adcock, I.M., and Barnes, P.J. 1996. Eicosanoid mediator expression in mononuclear and polymorphonuclear cells in normal subjects and patients with atopic asthma and cystic fibrosis. Thorax. 51:1223-1228.
12. Hardy, C.C., Bradding, P., Robinson, C., and Holgate, S.T. 1988. Bronchoconstrictor and antibronchoconstrictor properties of inhaled prostacyclin in asthma. J. Appl. Physiol. 64:1567-1574.
13. Pavord, I.D., Wong, C.S., Williams, J., and Tattersfield, A.E. 1993. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
14. 2 mechanism. J. Immunol. 151:2096-2104.
15. 2. Proc. Natl. Acad. Sci. USA. 85:6880-6884.
16. Sladek, K., et al. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 190:940-946.
17. 4 excretion in aspirin-sensitive asthma. Am. J. Respir. Crit. Care Med. 153:572-575.
18. Smith, W.L., and Dewitt, D.L. 1996. Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol. 62:167-215.
19. Langenbach, R., et al. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 83:483-492.
20. Morham, S.G., et al. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:473-482.
21. Dinchuk, J.E., et al. 1995. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 378:406-409.
22. Langenbach, R., Loftin, C., Lee, C., and Tiano, H. 1999. Cyclooxygenase knockout mice: models for elucidating isoform specific functions. Biochem. Pharmacol. In press.
23. Ewart, S., Levitt, R., and Mitzner, W. 1995. Respiratory system mechanics in mice measured by end-inflation occlusion. J. Appl. Physiol. 79:560-566.
24. Bates, J.H., Rossi, A., and Milic-Emili, J. 1985. Analysis of the behavior of the respiratory system with constant inspiratory flow. J. Appl. Physiol. 58:1840-1848.
25. Gavett, S.H., et al. 1997. Metal and sulfate composition of residual oil fly ash determines airway hyperreactivity and lung injury in rats. Environ. Res. 72:162-172.
26. Zeldin, D.C., et al. 1995. The rabbit pulmonary cytochrome P-450 arachidonic acid metabolic pathway: characterization and significance. J. Clin. Invest. 95:2150-2160.
27. Chulada, P.C., et al. 1996. Relative activities of retrovirally expressed murine prostaglandin synthase-1 and -2 depend on source of arachidonic acid. Arch. Biochem. Biophys. 330:301-313.
28. du Bois, R.M., Townsend, P.J., Cole, P.J., Haslam, P.L., and Turner-Warwick, M. 1981. Bronchoalveolar macrophages in sarcoidosis and cryptogenic fibrosing alveolitis. Clin. Allergy. 11:409-419.
29. Griswold, D.E., and Adams, J.L. 1996. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med. Res. Rev. 16:181-206.
30. Wilborn, J., et al. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95:1861-1868.
31. Renz, H., et al. 1992. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J. Allergy Clin. Immunol. 89:1127-1138.
32. 2α increases airway responsiveness of pulmonary airways in dogs. Prostaglandins. 28:537-543.
33. Walters, E.H., Parrish, R.W., Bevan, C., and Smith, A.P. 1981. Induction of bronchial hypersensitivity: evidence for a role of prostaglandins. Thorax. 36:571-574.
34. Chung, K.F., et al. 1986. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthetase inhibitor (OKY046) in allergic dogs. Am. Rev. Respir. Dis. 134:258-261.
35. Smith, W.G., Thompson, J.M., Kowalski, D.L., and McKearn, J.P. 1996. Inhaled misoprostol blocks guinea pig antigen-induced bronchoconstriction and airway inflammation. Am. Rev. Respir. Dis. 154:295-299.
36. 2 effect on T lymphocyte activation. J. Clin. Invest. 80:333-340.
37. Alam, R., et al. 1993. Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog. Am. Rev. Respir. Dis. 148:1066-1070.
38. Goulet, J.L., Snouwaert, J.N., Latour, A.M., Coffman, T.M., and Koller, B.H. 1994. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci. USA. 91:12852-12856.
39. Funk, C.D. 1996, The molecular biology of mammalian lipoxygenases and the quest for eicosanoid functions using lipoxygenase-deficient mice. Biochim. Biophys. Acta. 1304:65-84.
40. Demoly, P., et al. 1997. Prostaglandin H synthase 1 and 2 immunoreactivities in the bronchial mucosa of asthmatics. Am. J. Respir. Crit. Care Med. 155:670-675.
41. Walanga, R.W., et al. 1996. Constitutive expression of prostaglandin endoperoxide G/h synthase (PGHS)-2 but not PGHS-1 in human tracheal epithelial cells in vitro. Prostaglandins. 52:341-359.
42. Asano, K., Lilly, C.M., and Drazen, J.M. 1996. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am. J. Physiol. 271:L126-L131.
43. 2 biosynthesis in cyclooxygenase 1 or 2 null cells. J. Exp. Med. 187:517-523.